Denmark proposes 6 initiatives to lower drug prices – met with skepticism by industry association

Should pharmacies in Denmark be more competitive, and would this benefit patients in the end? The Danish Competition Council and the Association of the Pharmaceutical Industry, Lif, vehemently disagree.

Danish pharmacies have a monopoly on prescription drugs, says the country's competition council, urging that six initiatives be implemented to increase competition in the sector | Photo: Finn Frandsen

The Danish Competition Council has composed six recommendations to sharpen the competition between pharmacies in Denmark with the aim of securing lower drug prices, better service, and perhaps even more new products.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs